Esperion(ESPR) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Identification No.) WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 15, 2025 Esperion Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) Delaware 001-35986 26-1870780 (Commission File Number) (I.R.S. Employer 3891 Ranchero Drive, Suite 150 Ann Arbor, MI (Address of ...